topotecan has been researched along with Chromosomal Translocation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borgel, SD; Burkett, S; Butcher, DO; Hollingshead, M; Kenney, S; Raffeld, M; Schrump, DS; Shoemaker, RH; Stockwin, LH; Stone, G; Vistica, DT | 1 |
1 other study(ies) available for topotecan and Chromosomal Translocation
Article | Year |
---|---|
Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD34; Antineoplastic Agents; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Bevacizumab; Chromosomes, Human, Pair 17; Chromosomes, Human, X; Disease Models, Animal; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Oncogene Proteins, Fusion; Sarcoma; Topotecan; Translocation, Genetic; Transplantation, Heterologous; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2009 |